Alphabet Faces Dual Setbacks as Pharma Partnership Dissolves and EU Launches Fresh Probe
Published on 11/13/2025 at 17:55 | Redaktion boerse-global.de
Alphabet Inc., the parent company of Google, encountered significant headwinds on Thursday as two separate challenges emerged simultaneously. The technology conglomerate saw the collapse of a multi-billion dollar pharmaceutical collaboration while European regulators initiated a new investigation into its business practices, creating a perfect storm of negative developments.
The European Commission has turned its regulatory attention to Google’s treatment of news publishers within its search results. The investigation will examine whether the tech giant systematically disadvantages publishers who incorporate sponsored content or commercial third-party articles in their offerings.
This probe falls under the jurisdiction of the Digital Markets Act (DMA), one of Brussels’ most stringent regulatory Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
